<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Chromosomal translocations causing deregulated c-MYC expression are detectable in most Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cases </plain></SENT>
<SENT sid="1" pm="."><plain>However, little is known about the additional lesions necessary for <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Now, two independent studies, one of which was performed by Sander etÂ al. in this issue of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Cell, identify constitutive PI3K signaling and CyclinD3 mutations as cooperating lesions in both mice and humans </plain></SENT>
<SENT sid="3" pm="."><plain>The results have directly actionable therapeutic implications </plain></SENT>
</text></document>